Organogenesis Holdings Inc

자세한 내용은 Organogenesis Holdings Inc 회사

Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.

회사 정보

종목 코드 ORGO

회사 이름Organogenesis Holdings Inc

상장일Dec 02, 2016

CEOMr. Gary S. Gillheeney, Sr.

직원 수869

유형Ordinary Share

회계 연도 종료Dec 02

주소85 Dan Rd

도시CANTON

증권 거래소NASDAQ Capital Market Consolidated

국가United States of America

우편 번호02021-2810

전화17815750775

웹사이트https://investors.organogenesis.com

종목 코드 ORGO

상장일Dec 02, 2016

CEOMr. Gary S. Gillheeney, Sr.

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Glenn H. Nussdorf

Director

11.91M

--

Mr. Patrick Bilbo

Chief Operating Officer

447.51K

-8.12%

Mrs. Lori Freedman, J.D.

Chief Administrative and Legal Officer

419.71K

+150.65%

Mr. Brian Grow

Chief Commercial Officer

200.53K

-20.89%

Mr. Robert Cavorsi

Vice President - Strategy

189.16K

-0.19%

Mr. Antonio S. Montecalvo

Vice President - Health Policy

188.20K

+17.78%

Mr. Arthur S. Leibowitz, CPA

Lead Independent Director

187.61K

+0.78%

Ms. Prathyusha Duraibabu, CPA

Independent Director

148.64K

+3.64%

Mr. Jon L. Giacomin

Independent Director

142.62K

+2.31%

Dr. Gilberto Quintero, Ph.D.

Independent Director

140.67K

+1.04%

이름

이름/직위

직위

주식 보유

변동

Mr. Glenn H. Nussdorf

Director

11.91M

--

Mr. Patrick Bilbo

Chief Operating Officer

447.51K

-8.12%

Mrs. Lori Freedman, J.D.

Chief Administrative and Legal Officer

419.71K

+150.65%

Mr. Brian Grow

Chief Commercial Officer

200.53K

-20.89%

Mr. Robert Cavorsi

Vice President - Strategy

189.16K

-0.19%

Mr. Antonio S. Montecalvo

Vice President - Health Policy

188.20K

+17.78%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

사업별USD

이름

수익

비율

Advanced Wound Care

79.93M

92.20%

Surgical & Sports Medicine

6.77M

7.80%

데이터 없음

사업별

지역별

사업별USD

이름

수익

비율

Advanced Wound Care

79.93M

92.20%

Surgical & Sports Medicine

6.77M

7.80%

주식 보유 통계

마지막 업데이트: Sat, Jul 12

주주

주주 유형

주주

비율

Soleus Capital Management, L.P.

9.84%

Morgan Stanley & Co. LLC

9.49%

Nussdorf (Glenn H)

9.39%

Ades (Alan A)

8.82%

Erani (Dennis)

7.92%

Other

54.55%

주주

비율

Soleus Capital Management, L.P.

9.84%

Morgan Stanley & Co. LLC

9.49%

Nussdorf (Glenn H)

9.39%

Ades (Alan A)

8.82%

Erani (Dennis)

7.92%

Other

54.55%

주주 유형

주주

비율

Individual Investor

32.52%

Investment Advisor

16.60%

Corporation

14.12%

Investment Advisor/Hedge Fund

13.05%

Hedge Fund

12.78%

Research Firm

10.83%

Sovereign Wealth Fund

0.38%

Pension Fund

0.36%

Bank and Trust

0.06%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

301

127.82M

100.77%

+5.72M

2025Q1

324

125.21M

99.06%

+1.00M

2024Q4

344

121.01M

95.72%

-4.65M

2024Q3

354

109.09M

82.30%

-7.23M

2024Q2

369

107.79M

81.32%

-6.45M

2024Q1

374

102.47M

77.65%

-12.90M

2023Q4

378

102.14M

77.80%

-10.89M

2023Q3

390

113.75M

86.92%

-11.36M

2023Q2

400

112.98M

86.34%

-14.25M

2023Q1

400

117.68M

90.49%

-17.51M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Soleus Capital Management, L.P.

12.48M

9.84%

-6.53K

-0.05%

Mar 31, 2025

Morgan Stanley & Co. LLC

12.03M

9.49%

+286.33K

+2.44%

Mar 31, 2025

Nussdorf (Glenn H)

11.91M

9.39%

--

Jun 24, 2025

Ades (Alan A)

11.19M

8.82%

--

Jun 24, 2025

Erani (Dennis)

10.04M

7.92%

--

Jun 24, 2025

Organo PFG LLC

8.28M

6.53%

--

Jun 24, 2025

RED Holdings, L.L.C.

6.78M

5.35%

--

Jun 24, 2025

BlackRock Institutional Trust Company, N.A.

4.54M

3.58%

-205.40K

-4.33%

Mar 31, 2025

The Vanguard Group, Inc.

4.43M

3.49%

+841.62K

+23.44%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

3.10M

2.44%

+311.13K

+11.15%

Mar 31, 2025

4.615USD

Organogenesis Holdings Inc

4.615

개요

회사

금융